학술논문
441P Real-world efficacy of ribociclib (RIB) + aromatase inhibitor (AI)/fulvestrant (FUL) in subgroups of special interest: 5th interim analysis (IA) of the RIBANNA study
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S366-S367
Subject
Language
ISSN
0923-7534